CSPC Pharmaceutical Group Limited: Overweight trials

The registry lists 11 Overweight studies with CSPC Pharmaceutical Group Limited as lead sponsor. 4 are open to participants now and 0 have results posted.

Phase 1 6Phase 2 4Phase 3 1(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Efficacy and Safety of SYH2069 Injection in Obese Participants Without Diabetes.Not yet recruitingNCT07803991Phase 2
• A Study of SYH2092 Injection in Healthy ParticipantsNot yet recruitingNCT07776041Phase 1
• A Single Ascending Dose and Multiple Ascending Doses Study of SYH2082 Injection in Healthy ParticipantsRecruitingNCT07532655Phase 1
• The Safety, Tolerability, and Pharmacokinetics of of SYH9017 in Chinese Participants With Overweight and ObesityRecruitingNCT06830343Phase 1
• A Study of SYH2082 Injection in Healthy ParticipantsActive, not recruitingNCT07736404Phase 1
• A Study of SYH2069 Injection in Healthy ParticipantsActive, not recruitingNCT07736391Phase 1
• A Study of TG103 Injection in the Management of Non-diabetic Overweight or ObesityCompletedNCT06226090Phase 2
• A Study of TG103 Injection in Non-diabetic Overweight or ObesityCompletedNCT05997576Phase 3
• A Study of TG103 Injection in Overweight or ObesityStatus unknownNCT05299697Phase 2
• A Study of TG103 Injection in Overweight/Obese Subjects With Type 2 DiabetesStatus unknownNCT05063253Phase 2
• A Study of TG103 Injection in Overweight/Obese Subjects Without DiabetesCompletedNCT04855292Phase 1